Suspended NA INTERVENTIONAL NCT00184938

Opioid Receptors Influence Ischemia-Reperfusion Injury

Opioid Induced Acute Preconditioning

Sponsor: Radboud University Medical Center

Interventions Technetium-TC99m-labeled Annexin A5 forearm ischemic exercise morphine naloxone ten minute forearm ischemia

Updated 6 times since 2017 Last updated: Mar 27, 2008 Started: Jan 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

This trial was suspended. No reason was provided.

This NA trial investigates Ischemia-Reperfusion Injury and is currently suspended. Radboud University Medical Center leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Suspended NA
Jul 2024 — Sep 2024 [monthly]

Suspended NA
Mar 2022 — Jul 2024 [monthly]

Suspended NA
Jan 2021 — Mar 2022 [monthly]

Suspended NA
Jun 2018 — Jan 2021 [monthly]

Suspended NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Suspended NA

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Radboud University Medical Center

Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nijmegen, Netherlands